These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Critical analysis of drug policy in Brazil]. Zepeda Bermúdez JA; de Albuquerque Possas C Bol Oficina Sanit Panam; 1995 Sep; 119(3):270-7. PubMed ID: 7576188 [No Abstract] [Full Text] [Related]
3. Realizing two-tiered innovation policy through drug regulation. Ridgway WE Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807 [No Abstract] [Full Text] [Related]
4. Drug quality control work in Daru: observations during 1983-1986. Kibwage IO; Ogeto JO; Maitai CK; Rutere G; Thuranira J; Ochieng' A East Afr Med J; 1992 Oct; 69(10):577-80. PubMed ID: 1473513 [TBL] [Abstract][Full Text] [Related]
5. [Harmful effects of drugs. Liability of the manufacturers against insurance claims for damages]. Dahl B Ugeskr Laeger; 1984 Sep; 146(36):2726-8. PubMed ID: 6515894 [No Abstract] [Full Text] [Related]
7. [The birth of new drugs]. Petrányi G Orv Hetil; 1968 May; 109(21):Suppl:1-6. PubMed ID: 5720715 [No Abstract] [Full Text] [Related]
8. Regulating drugs for effectiveness and safety: a public health perspective. Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264 [No Abstract] [Full Text] [Related]
9. [Standardization as a basis planning and administration in drug industry and pharmacy (II)]. Wagler M Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874 [No Abstract] [Full Text] [Related]
10. [Responsibility for drug testing and control]. Büchi J Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866 [No Abstract] [Full Text] [Related]
12. Negotiating reality: the construction of enforceable pharmaceutical standards. Parrish RH Food Drug Law J; 2002; 57(3):457-74. PubMed ID: 12710406 [No Abstract] [Full Text] [Related]
13. 3. Drug regulations in Switzerland and their application. Hippenmeier F Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448 [No Abstract] [Full Text] [Related]
16. National drug policy in Nigeria. Interview by Daphne A. Fresle. Kuti OR J Public Health Policy; 1992; 13(3):367-73. PubMed ID: 1401053 [No Abstract] [Full Text] [Related]
17. [Technical-administrative aspects of the registration of pharmaceutical specialities]. Marconi M; Battaglino G Boll Chim Farm; 1979 Mar; 118(3):118-34. PubMed ID: 475904 [No Abstract] [Full Text] [Related]